High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: Epidemiology and antifungal susceptibility

References

• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309–17.
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005;41:1232–9.
   PubMed Web of Science ®Google Scholar
• Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008;21:606–25.
   PubMed Web of Science ®Google Scholar
• Levin AS, Costa SF, Mussi NS, Basso M, Sinto SI, Machado C, . Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis 1998;30:243–9.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002;50:243–60.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical and Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. 2nd. Approved standard M27-A2. Wayne, PA: NCCLS; 2002.
   Google Scholar
• Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, . Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006;44:819–26.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, . Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol 2008;46:2620–9.
   PubMed Web of Science ®Google Scholar
• Sugita T, Tajima M, Tsubuku H, Tsuboi R, Nishikawa A. Quantitative analysis of cutaneous malessezia in atopic dermatitis patients using real-time PCR. Microbiol Immunol 2006;50:549–52.
   PubMed Web of Science ®Google Scholar
• Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis 1999;34:213–20.
   PubMed Web of Science ®Google Scholar
• Bakir M, Cerikcioglu N, Barton R, Yagci A. Epidemiology of candidemia in a Turkish tertiary care hospital. APMIS 2006;114:601–10.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, . Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006;44:2816–23.
   PubMed Web of Science ®Google Scholar
• Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, . Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 2006;12:75–80.
   PubMed Web of Science ®Google Scholar
• Almirante B, Rodríguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, . Risk factors and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006;44:1681–5.
   PubMed Web of Science ®Google Scholar
• Levy I, Rubin LG, Vasishtha S, Tucci V, Sood KS. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998;26:1086–8.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Doern GV, Fluit AC, Verhoef J, Sader HS, . International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn Microbiol Infect Dis 1999;35:19–25.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. J Clin Microbiol 1998;36:1886–9.
   PubMed Web of Science ®Google Scholar
• Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995–2004. Pediatrics 2006;117:1680–7.
   PubMed Web of Science ®Google Scholar
• van Asbeck EC, Huang YC, Markham AN, Clemons KV, Stevens DA. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 2007;164:287–93.
   PubMed Web of Science ®Google Scholar
• Marco F, Danés C, Almela M, Jurado A, Mensa J, de la Bellacasa JP, . Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996–2001). Diagn Microbiol Infect Dis 2003;46:259–64.
   PubMed Web of Science ®Google Scholar
• Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 2004;53:283–9.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, . International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 2001;39:3254–9.
   PubMed Web of Science ®Google Scholar